Experts unite to make cancer trial results easier to compare
NCT ID NCT03676010
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study brings together cancer experts to agree on standard definitions for key measurements used in cancer clinical trials, such as how long patients live without their cancer getting worse. Currently, different trials define these measurements in different ways, making it hard to compare results. The goal is to create clear guidelines that all future cancer trials can follow, helping researchers and doctors better understand which treatments work best.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
265 people
The number who actually took part.
- Started
-
Sep 2009
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
No patient will be included.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Sarcoma / GIST * Breast cancer * Pancreatic cancer * Renal cell carcinoma * adjuvant colon cancer * early non small cell lung cancer Exclusion Criteria : \- Individual patient data unavailable
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Georges François Leclerc
Dijon, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut du Cancer de Montpellier
Montpellier, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- Can colorectal surgery patients go home in two days?
- Two-Drug combo targets stubborn KRAS lung cancer
- New PET tracer aims to light up hidden cancer targets
- Smaller chest drain may speed recovery after lung cancer surgery